DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Private Equity
Grand Cayman
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
This entity has not been resolved onto another DFX graph by a shared identifier. A name match elsewhere would be a candidate, never an identity, and none is recorded.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| GHO Capital Vanquish LP | 2024 | Unknown | Private Equity Fund | n/a | $446M | 0 |
| Zebra 1 Co-Invest LP | 2024 | Unknown | Private Equity Fund | n/a | $318M | 0 |
| Adesso Co-Invest LP | 2023 | Unknown | Private Equity Fund | n/a | $21.8M | 0 |
| Material Co-Invest LP | 2023 | Unknown | Private Equity Fund | n/a | $53.3M | 0 |
| Zebra Co-Invest LP | 2023 | Early deployment | Private Equity Fund | n/a | $72.1M | 0 |
| Dolly Co-Invest LP | 2023 | Early deployment | Private Equity Fund | n/a | $47.3M | 0 |
| Lotus Co-Invest LP | 2023 | Early deployment | Private Equity Fund | n/a | $70.3M | 0 |
| Jarvis Co-Invest LP | 2023 | Early deployment | Private Equity Fund | n/a | $14.9M | 0 |
| GHO Capital Virtue LP | 2023 | Early deployment | Private Equity Fund | n/a | $364M | 0 |
| GHO Capital III Sma 2 LP | 2022 | Early deployment | Private Equity Fund | n/a | $124M | 0 |
| GHO Capital III LP | 2022 | Early deployment | Private Equity Fund | n/a | $1.5B | 0 |
| Apollo Co-Invest (US) LP | 2022 | Early deployment | Private Equity Fund | n/a | $66.4M | 0 |
| GHO Capital III US Aiv LP | 2022 | Unknown | Private Equity Fund | n/a | $106M | 0 |
| GHO Capital III Sma 1 LP | 2022 | Early deployment | Private Equity Fund | n/a | $42.8M | 0 |
| Churchill Co-Invest LP | 2022 | Early deployment | Private Equity Fund | n/a | $758M | 0 |
| Apollo Co-Invest LP | 2022 | Early deployment | Private Equity Fund | n/a | $213M | 0 |
| Extra Co-Invest LP | 2021 | Unknown | Private Equity Fund | n/a | $170M | 0 |
| Mint Co-Invest LP | 2021 | Unknown | Private Equity Fund | n/a | $54.0M | 0 |
| Barnaby Co-Invest LP | 2021 | Wound down | Private Equity Fund | n/a | $65,108 | 0 |
| Evidence Co-Invest LP | 2021 | Unknown | Private Equity Fund | n/a | $405M | 0 |
| Authentic Co-Invest LP | 2020 | Harvest | Private Equity Fund | n/a | $290,475 | 0 |
| Linimed Co-Invest LP | 2020 | Mature | Private Equity Fund | n/a | $260M | 0 |
| Saffron Co-Invest LP | 2020 | Harvest | Private Equity Fund | n/a | $628,558 | 0 |
| Alfa Co-Invest LP | 2020 | Harvest | Private Equity Fund | n/a | $21,581 | 0 |
| GHO Capital Fund II LP | 2020 | Successor fundraising | Private Equity Fund | n/a | $1.6B | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Alcami Corporation | n/a | unknown | unknown | n/a | n/a | active |
| Scientist.com | n/a | unknown | unknown | n/a | n/a | active |
| FotoFinder | n/a | unknown | unknown | n/a | n/a | active |
| Avid Bioservices | n/a | unknown | unknown | n/a | n/a | active |
| Sapio Sciences | n/a | unknown | unknown | n/a | n/a | active |
| RoslinCT | n/a | unknown | unknown | n/a | n/a | active |
| Biocare Medical | n/a | unknown | unknown | n/a | n/a | active |
| Genesis Research | n/a | unknown | unknown | n/a | n/a | active |
| Sanner | n/a | unknown | unknown | n/a | n/a | active |
| ClearView Healthcare Partners | n/a | unknown | unknown | n/a | n/a | active |
| ELIQUENT Life Sciences | n/a | unknown | unknown | n/a | n/a | active |
| Velocity Clinical Research | n/a | unknown | unknown | n/a | n/a | active |
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan